Dany:

   what briggs says is that "the levels are not thought to be sufficiently
high after therapeutic doses to affect the infant, the manufacturer considers
the drug contraindicated in nursing mothers,. the reason given for this is
the increased sensitivivty of the newborn or premature infants to
antihistamines."

     i think that we can separate the known from the manufacturer who want to
cover his/her posterior!

                     Patricia